Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

AIMS: No therapy has shown to reduce the risk of hospitalization for heart failure across the entire range of ejection fractions seen in clinical practice. We assessed the influence of ejection fraction on the effect of the sodium–glucose cotransporter 2 inhibitor empagliflozin on heart failure outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Javed, Packer, Milton, Filippatos, Gerasimos, Ferreira, Joao Pedro, Zeller, Cordula, Schnee, Janet, Brueckmann, Martina, Pocock, Stuart J, Zannad, Faiez, Anker, Stefan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825259/
https://www.ncbi.nlm.nih.gov/pubmed/34878502
http://dx.doi.org/10.1093/eurheartj/ehab798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825259/
https://www.ncbi.nlm.nih.gov/pubmed/34878502
http://dx.doi.org/10.1093/eurheartj/ehab798

Ejemplares similares